|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
2 Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States; Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
3 Rochester, New York, United States; Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
* To whom correspondence should be addressed. E-mail: terry_wright{at}urmc.rochester.edu.
Pneumocystis carinii is an opportunistic fungal pathogen that causes pneumonia (PCP) in immunocompromised individuals. Recent studies have demonstrated that the hosts immune response is clearly responsible for the majority of the pathophysiological changes associated with PCP. P. carinii interacts closely with alveolar epithelial cells (AECs), however the nature and pathological consequences of the epithelial response remain poorly defined. Monocyte chemotactic protein-1 (MCP-1) is involved in lung inflammation, immunity, and epithelial repair, and is upregulated during PCP. To determine whether AECs are an important source of MCP-1 in the P. carinii-infected lung, in vivo and in vitro studies were performed. In situ hybridization showed that MCP-1 mRNA was localized to cells with morphological characteristics of AECs in the lungs of infected mice. In vitro studies demonstrated that P. carinii stimulated a time- and dose-dependent MCP-1 response in primary murine type II cells, which was preceded by JNK activation. Pharmacological inhibition of JNK nearly abolished P. carinii-stimulated MCP-1 production, while ERK, p38 MAPK, and TNF receptor signaling were not required. Furthermore, delivery of a JNK inhibitory gene specifically to pulmonary epithelial cells using a recombinant adenovirus vector blocked the early lung MCP-1 response following intratracheal instillation of infectious P. carinii. JNK inhibition did not affect P. carinii-stimulated production of macrophage inflammatory protein-2 in vitro or in vivo, indicating that multiple signaling pathways are activated in P. carinii-stimulated AECs. These data demonstrate that AECs respond to P. carinii in a pro-inflammatory manner that may contribute to the generation of immune-mediated lung injury.
This article has been cited by other articles:
![]() |
M. Meyer, F. Huaux, X. Gavilanes, S. van den Brule, P. Lebecque, S. Lo Re, D. Lison, B. Scholte, P. Wallemacq, and T. Leal Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis Am. J. Respir. Cell Mol. Biol., November 1, 2009; 41(5): 590 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Beck, A. M. Preston, S. E. Wilcoxen, S. B. Morris, A. Sturrock, and R. Paine III Critical Roles of Inflammation and Apoptosis in Improved Survival in a Model of Hyperoxia-Induced Acute Lung Injury in Pneumocystis murina-Infected Mice Infect. Immun., March 1, 2009; 77(3): 1053 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Park, D.-R. Ryu, J. J. Li, D.-S. Jung, S.-J. Kwak, S. H. Lee, T.-H. Yoo, S. H. Han, J. E. Lee, D. K. Kim, et al. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells Am J Physiol Renal Physiol, September 1, 2008; 295(3): F749 - F757. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |